(BUSINESS WIRE) October 10, 2018
EAST LYME, Conn. Phesi, a technology-enabled, data-driven provider of premier clinical development services, today announced it is a finalist for a 2018 Scrip Award, one of the pharmaceutical and biotech industries’ most prestigious honors. The company has been selected as one of six finalists in the Best Technological Development in Clinical Trials – Tech Sponsor-focused category, which “recognize[s] the promising and disruptive role that digital health technology now plays in clinical drug development,” according to the Scrip Awards 2018 website.
Read the full press release at Business Wire.